£500K
The seed round was led by Parkwalk Advisors and includes backing from Amadeus Capital Partners, Crista Galli, RCA, and Oxbridge Angels to fund the market launch of the CUE1 device.
"We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials."
